Skip to main content

Table 2 Comparison of variant classifications between a subset of novel PathOS variants submitted to a commercial tertiary analysis platform showing concordance

From: Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics

CTAP PathOS
Benign Likely benign VUS Likely pathogenic Pathogenic
Benign 0 0 0 0 0
Likely benign 1 0 0 0 0
VUS 1 0 248 17 29
Likely pathogenic 0 0 1 1 9
Pathogenic 0 0 0 0 0